Marathon Capital Management / BSFA
Marathon Capital Management’s Ani Pharmaceuticals Inc Position
Does Marathon Capital Management own Ani Pharmaceuticals Inc (BSFA)? Yes — 72.6K shares worth $6M (+1.25% of its 13F portfolio) as of Q1 2026, up from 69.7K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
72.6K
% of Portfolio
+1.25%
Quarters Held
19
currently held
Position History BSFA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 72.6K | $6M | +1.25% |
| Q4 2025 | 69.7K | $5M | +1.18% |
| Q3 2025 | 69.7K | $6M | +1.46% |
| Q2 2025 | 72.0K | $5M | +1.20% |
| Q1 2025 | 69.2K | $5M | +1.23% |
| Q4 2024 | 69.9K | $4M | +0.97% |
| Q3 2024 | 70.0K | $4M | +1.01% |
| Q2 2024 | 70.3K | $4M | +1.14% |
| Q1 2024 | 71.2K | $5M | +1.17% |
| Q4 2023 | 69.8K | $4M | +0.97% |
| Q3 2023 | 71.7K | $4M | +1.05% |
| Q2 2023 | 68.6K | $4M | +0.91% |
| Q1 2023 | 84.9K | $3M | +0.83% |
| Q4 2022 | 72.9K | $3M | +0.81% |
| Q3 2022 | 72.9K | $2M | +0.67% |
| Q2 2022 | 74.5K | $2M | +0.71% |
| Q1 2022 | 75.0K | $2M | +0.61% |
| Q4 2021 | 74.8K | $3M | +0.81% |
| Q3 2021 | 74.2K | $2M | +0.55% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marathon Capital Management’s full portfolio or all institutional holders of BSFA.